Medical Developments (MVP.AX)
Trading: HOLD @ $4.8
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has been constructed to highlight the existence of a trend for an assocaited timeframe. Trend determining indicators can be used in short, medium or long term timeframes & determines if the stock is trending or ranging. Once the trend status is quantified, this can then be coupled to additional indicators to add a significant advantage to the trading strategy.
Medical Developments (ASX:MVP)
The Supertrend is a trend following indicator which identifies uptrends and downtrends. The SuperTrend indicator is calculated utilising the ATR to offset the indicator from the common price. Before understanding the supertrend indicator, understanding the ATR is essential as super trend employs ATR values to calculate the indicator values. This indicator fluctuates above and below 0 signalling the current direction of the trend. This is a lagging trend indicator that assists in defining trend directions does not perform well in ranging markets.
Calculation: Supertrend (SUP) :
1) Basic Upper band = (High + Low) / 2 + Multiplier * ATR;
2) Basic Lower band = (High + Low) / 2 - Multiplier * ATR
3) Final Upper band = IF((Basic Upper band < Final Upper band(yest)) OR (Close(yest) > Previous Final Upper band(yest))) THEN (Basic Upper band) ELSE Final Upper band(yest));
4) Final Lower band = IF((Basic Lower band > Final Lowerband (yest)) OR (Close(yest) < Final Lower band(yest))) THEN (Basic Lower band) ELSE Final Lower band(yest));
5) Supertrend = IF(Close <= Final Upper band ) THEN Final Upper band ELSE Final Lower band;
Where Multiplier = 3; Period=14
PROFILE: Medical Developments (MVP.AX)
Stock Exchange: ASX
Company: Medical Developments
Ticker Codes: | MVP.AX | ASX:MVP |
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians. The company operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. Medical Developments International Limited is headquartered in Scoresby, Australia.
|TRS Reject Shop||2.34||15.8||571,078||-0.17||BULLISH|
|MNS Milnes Holdings||0.37||12.3||2,277,569||0.07||BULLISH|
|LYC Lynas Corporation||2.4||9.6||12,451,685||0.41||BULLISH|
|AJX Alexium International||0.12||9.1||1,013,972||-0.02||BULLISH|
|DNA Donaco International||0.19||8.6||223,280||0.05||BULLISH|
|TZN Terramin Australia||0.13||8.3||220,506||0.03||BULLISH|